// RET-10
Retatrutide 10mg
Lyophilized Vial · Research Grade
FROM
$89.99
01 ≥98% Purity 02 ↓ COA 03 Same-Day Dispatch
Retatrutide. A synthetic thirty-nine-amino-acid peptide in the incretin-mimetic family. Eli Lilly designation LY3437943.
Specifications
Compound
Retatrutide 10mg
CAS Number
2381089-83-2
Molecular Formula
C₂₂₁H₃₄₃N₄₅O₆₈
Purity
≥98% (HPLC verified)
Test Method
Independent third-party HPLC & mass-spectrometry; COAs published per batch
Quantity
10 mg per vial
Molecular Weight
4731.39 g/mol
Sequence
Modified 39-amino-acid peptide; contains aminoisobutyric acid (Aib) at positions 2 and 20, alpha-methyl-L-leucine at position 13, a C-terminal amide, and Lys-17 conjugated to a C20 fatty diacid (1,20-eicosanedioic acid) via a γGlu linker
Form
Lyophilized white powder
Storage
2–8 °C sealed; -20 °C for long-term storage; protect from light and moisture; refrigerated after reconstitution; avoid repeated freeze-thaw cycles
Reconstitution
Reconstitute lyophilized powder with bacteriostatic water. Add solvent slowly down the side of the vial to minimize foaming; the lipidated peptide is shear-sensitive. Gently swirl until fully dissolved — do not shake. Store reconstituted vial refrigerated at 2–8 °C. Lyophilized form is stable at -20 °C until expiration. Protect from light.
Compliance
Supplied strictly for in-vitro and laboratory research purposes. Not for human or veterinary use. Not for consumption. Not intended to diagnose, treat, cure, or prevent any disease. Retatrutide (LY3437943) is an investigational compound owned by Eli Lilly and Company and is not currently approved for therapeutic use by any global regulatory authority. This research-grade material is supplied for laboratory research applications only and should not be used in any clinical or self-administration context. By purchasing, the buyer confirms qualification to handle research-grade peptides under applicable laboratory protocols.
